Literature DB >> 12225864

Expression of glutamate transporters and ionotropic glutamate receptors in GLAST knockout mice.

Yuto Ueda1, Taku Doi, Noriko Tsuru, Jun Tokumaru, Yoshio Mitsuyama.   

Abstract

In order to investigate the molecular mechanism underlying high seizure susceptibility of GLAST knockout mice, we carried out Western blotting for the expression of GLT-1, EAAC-1, and several kinds of glutamate receptors in the hippocampus and the cortex. Although no significant difference was observed between GLAST (+/+) and (-/-) mice in terms of expression of GLT-1 and EAAC-1 in the hippocampus, these proteins were over-expressed in the frontal cortex in GLAST (-/-) mice (GLT-1, about 210% increase; EAAC-1, about 180% increase). Expression of hippocampal Glu-R1 and Glu-R2 in GLAST (-/-) mice was remarkably increased (Glu-R1, about 140% increase; Glu-R2, about 160% increase), while Glu-R3 and NMDA receptors levels (NMDA-R1, 2A and 2B) were equal to those in control. Cortical levels of Glu-R1, -R2 and -R3 receptors in GLAST (-/-) mice were remarkably decreased (Glu-R1, about 60% decrease; Glu-R2, about 60% decrease; Glu-R3, about 70% decrease), while NMDA receptors were remarkably increased in comparison to those in GLAST (+/+) mice (N-R1, about 150% increase; N-R2A, about 150% increase; N-R2B, about 140% increase). These data suggest that the increased susceptibility to seizures in GLAST (-/-) mice might be derived from increased expression of Glu-R1 in the hippocampus coupled with decreased cortical expression of Glu-R2 and increased NMDA-R1 and -2A, -2B expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225864     DOI: 10.1016/s0169-328x(02)00325-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

1.  Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction.

Authors:  Anna Kiryk; Tomomi Aida; Kohichi Tanaka; Pradeep Banerjee; Grzegorz M Wilczynski; Ksenia Meyza; Ewelina Knapska; Robert K Filipkowski; Leszek Kaczmarek; Wojciech Danysz
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

Review 2.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST.

Authors:  Rose-Marie Karlsson; Louise Adermark; Anna Molander; Stephanie Perreau-Lenz; Erick Singley; Matthew Solomon; Andrew Holmes; Kohichi Tanaka; David M Lovinger; Rainer Spanagel; Markus Heilig
Journal:  Neuropharmacology       Date:  2012-02-09       Impact factor: 5.250

Review 4.  Brain imaging in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster; Joseph O'Neill; David R Rosenberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

Review 5.  Mitochondria, oxidative stress, and temporal lobe epilepsy.

Authors:  Simon Waldbaum; Manisha Patel
Journal:  Epilepsy Res       Date:  2009-10-21       Impact factor: 3.045

6.  NEUROBIOLOGICAL EVIDENCE SUPPORTING GLUTAMATE'S ROLE IN PEDIATRIC OBSESSIVE COMPULSIVE DISORDER.

Authors:  Frank P MacMaster; David R Rosenberg
Journal:  Child Adolesc Psychopharmacol News       Date:  2010-12

Review 7.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

Review 8.  Translational neuroimaging research in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.